"In my view, healthcare is ripe with opportunities for technology to enhance and influence long-term outcomes, in a set-up traditionally reliant on episodic interactions. I'm excited to be part of this evolving landscape."
Akshay Rai leads investments in healthcare and life sciences at Premji Invest. Since joining in 2010, Akshay has held multiple roles at PI across India and the U.S. Most recently, he helped start U.S. healthcare investments for PI, which includes the firm’s investments in Moderna, Devoted Health, Iora, Adimab, and Sondermind. Akshay is passionate about the urgent need for innovation in healthcare delivery and drug development. His focus is on platforms that leverage emerging technologies to discover new treatments and better care models, leading to improved clinical outcomes and patient experience. He is excited to partner with exceptional founders who are driving these changes and creating a lasting impact on the lives of millions of patients.
Prior to joining PI, Akshay was a healthcare analyst at Citigroup India. He received a Bachelor of Engineering degree from NITK Suratkal and an M.B.A. from IIM Bangalore. In his free time, he is equally comfortable relaxing with a book or being outdoors. His favorite activities are playing pick-up soccer and climbing rocks with his 10-year-old son.
Partnering with SonderMind to improve mental health access
Partnering with SonderMind to improve mental health access
Partnering with Elemy to deliver high quality paediatric autism care
Partnering with Elemy to deliver high quality paediatric autism care
Partnering with Unite Us, Driving Broader Access to Social Care Networks
Partnering with Unite Us, Driving Broader Access to Social Care Networks
Superfluid Dx - Leveraging cf-mRNA for early disease detection
Superfluid Dx - Leveraging cf-mRNA for early disease detection
Meet Rachel, your hospital-certified confidante
Meet Rachel, your hospital-certified confidante
Gene, Cell, + RNA Therapy Landscape Report
Gene, Cell, + RNA Therapy Landscape Report
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
Bicara Therapeutics to Present at the 2023 Jefferies Global Healthcare Conference
Bicara Therapeutics to Present at the 2023 Jefferies Global Healthcare Conference
CMS Announces Multi-State Initiative to Strengthen Primary Care
CMS Announces Multi-State Initiative to Strengthen Primary Care
Moving health equity from goals to reality
Moving health equity from goals to reality
Treating Troubling Tumors: CAR T Therapy For Aggressive Childhood T Cell Leukemia
Treating Troubling Tumors: CAR T Therapy For Aggressive Childhood T Cell Leukemia
The Changing Landscape Of Primary Care: Effects Of The ACA And Other Efforts Over The Past Decade
The Changing Landscape Of Primary Care: Effects Of The ACA And Other Efforts Over The Past Decade
2023 may bring progress in SDOH tech, telehealth and interoperability
2023 may bring progress in SDOH tech, telehealth and interoperability
Included Health Introduces New, Virtual-to-Home, Care Model
Included Health Introduces New, Virtual-to-Home, Care Model
Included Health’s Communities Offering Brings Support to Millions of LGBTQ+ and Black Individuals Across the Nation
Included Health’s Communities Offering Brings Support to Millions of LGBTQ+ and Black Individuals Across the Nation
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx
Mental Health Leader SonderMind to Provide More Personalized Care with Acquisition of Mindstrong Technology
